ScienceMag.org

Read our COVID-19 research and news.

Leslie K. Ferrarelli

Leslie K. Ferrarelli

Science Signaling, AAAS, Washington, DC 20005, USA

Twitter

Latest Stories

Inflammatory pain revisits development

By Michael Funk, Leslie K. FerrarelliJul. 3, 2020
New connections: Neurodevelopmental switches

By Leslie K. FerrarelliJun. 30, 2020
Speedy screen for tumor therapies

By Michael Funk, Leslie K. FerrarelliJun. 19, 2020
Therapeutic potential of EBV infection

By Leslie K. FerrarelliJun. 2, 2020
Chaperones put the brakes on opioids

By Michael Funk, Leslie K. FerrarelliMay. 8, 2020
Tumor’s loss is clinician’s gain

By Leslie K. FerrarelliMay. 5, 2020
Polκ manages stress without mutagenesis

By Michael Funk, Leslie K. FerrarelliMay. 1, 2020
Coordinated by oxidative stress

By Michael Funk, Leslie K. FerrarelliApr. 17, 2020
Three hits, one drug

By Leslie K. FerrarelliApr. 7, 2020
Stressed into generating amyloid-β

By Michael Funk, Leslie K. FerrarelliMar. 20, 2020
Inducing mortality by targeting mortalin

By Michael Funk, Leslie K. FerrarelliMar. 13, 2020
Timing matters in combination therapy

By Leslie K. FerrarelliMar. 10, 2020
Palmitoylation makes the switch for EGFR

By Michael Funk, Leslie K. FerrarelliMar. 6, 2020
Treatments from the dark kinome

By Michael Funk, Leslie K. FerrarelliFeb. 21, 2020
New connections: Targeted treatment options for SCLC

By Leslie K. FerrarelliFeb. 11, 2020
Predicting resistance to KRAS inhibitors

By Leslie K. FerrarelliJan. 14, 2020

Latest News

Staff Writers